Extended Data Table 2 Clinical characteristics of untreated, control breast cancer patients

From: Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial

  1. Table showing the age (years) at primary diagnosis, age (years) at CTC enumeration, subtype of most recent biopsy (% of ER-positive cells, % of PR-positive cells, % of Ki67-positive cells, HER2 amplification status, histologic subtype (ductal, lobular, mucinous/neuroendocrine), next-generation sequencing (NGS), site of metastasis, number and type of previous systemic treatment lines. nd: not determined.
Back to article page